Knowledge, attitudes, and practices among Saudi women regarding cervical cancer, human papillomavirus (HPV) and corresponding vaccine

Jradi, Hoda; Bawazir, Amen

doi:10.1016/j.vaccine.2018.11.065

Cited by 45 publications

(45 citation statements)

References 35 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Our results show that physicians are often presented with parental barriers regarding vaccine safety, efficacy, and lack of information about the vaccine (Table 1). Additionally studies performed in Lebanon and neighboring countries have shown low awareness rates regarding HPV (Alsaad et al, 2012;Ortashi et al, 2013;Abou El-Ola et al, 2018;Jradi and Bawazir, 2019). Future efforts to increase patients and parents knowledge regarding HPV are warranted in the region.…”

Section: Discussionmentioning

confidence: 97%

Barriers, Attitudes and Clinical Approach of Lebanese Physicians Towards HPV Vaccination; A Cross- Sectional Study

Jaoude

Saad

Farha

et al. 2019

Asian Pac J Cancer Prev

View full text Add to dashboard Cite

Objectives: HPV infection is associated with the development of cervical and oropharyngeal cancer. HPV vaccination prevents cervical cancer, but is still not part of Lebanon's routine vaccination schedule. As such, understanding physicians' practice towards HPV vaccination is essential. Material and Methods: We conducted a cross-sectional study in Greater Beirut, Lebanon to assess the barriers, attitudes and clinical approach of Lebanese physicians towards HPV vaccination. We also aimed to analyze the factors associated with physicians' barriers to HPV vaccination. Results: In total, 228 physicians completed the survey. Our results show that physicians and parents consider the cost of HPV vaccination to be a main barrier (58.9% and 80.7% respectively). Also, parents tend to have concerns about vaccine safety (78.1%), efficacy (68.6%), and lack education concerning HPV infection (81.8%). Furthermore, female physicians tend to have fewer barriers when compared to male physicians (aOR = 0.39; p-value = 0.007). Additionally, physicians who completed residency programs in the USA also showed fewer barriers when compared to physicians who completed Lebanese residency programs (aOR = 0.24; p-value = 0.040). Finally, physicians with higher knowledge score have fewer barriers when compared to those with lower knowledge scores (aOR = 0.42; p-value = 0.018). Conclusions: Physician gender, residency program and level of knowledge play a role in HPV vaccine barriers and recommendation in Lebanon. Future improvements in cost and awareness about HPV might improve vaccination rates. Creating uniform practices towards HPV vaccine is warranted to improve patient care.

show abstract

Section: Discussionmentioning

confidence: 97%

Barriers, Attitudes and Clinical Approach of Lebanese Physicians Towards HPV Vaccination; A Cross- Sectional Study

Jaoude

Saad

Farha

et al. 2019

Asian Pac J Cancer Prev

View full text Add to dashboard Cite

show abstract

“…According to the study protocol, 84.8% of the participants showed poor total knowledge scores, similar to the findings of several studies in both developed and developing countries. [ 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 ] Thus, increasing the level of knowledge of cervical cancer in Saudi Arabia is important for the promotion of healthy behaviors and the use of preventive methods.…”

Section: Discussionmentioning

confidence: 99%

“…[ 14 15 ] Many studies, including those conducted in Saudi Arabia, have highlighted the lack of awareness of HPV infection and cervical cancer in the general population, as well as among health professionals. [ 16 17 18 19 20 21 22 23 24 25 26 27 ] However, data on the perception and knowledge of HPV and cervical cancer among people living in the northern region of Saudi Arabia are limited, particularly in terms of the levels of knowledge on cervical cancer and its preventive vaccination.…”

Section: Introductionmentioning

confidence: 99%

Human papillomavirus and its vaccination: Knowledge and attitudes among female university students in Saudi Arabia

Altamimi

2020

J Family Med Prim Care

View full text Add to dashboard Cite

Context: College students worldwide have low levels of knowledge on human papillomavirus (HPV)-related diseases, highlighting the lack of awareness about HPV infection. To date, no study has examined the level of knowledge of cervical cancer and the HPV vaccine in the northern region of Saudi Arabia. Aim: This study aimed to assess the level of knowledge of cervical cancer and its risk factors, as well as HPV vaccine acceptance among female students in Saudi Arabia enrolled in health colleges. Methods: A descriptive cross-sectional survey was conducted using a valid and reliable self-administered questionnaire. The questionnaire was completed by 966 female students enrolled at the University of Hail, northern region of Saudi Arabia, with a response rate of 83.5%. The main outcome measure was the identification of the knowledge gap pertaining to HPV infection and its prophylactic vaccine. Results: The findings highlighted a lack of knowledge about cervical cancer, Pap smears, and HPV vaccine among most female university students. The knowledge score positively correlated to the duration of education. Students enrolled in applied medical science and medical colleges showed significantly higher knowledge scores, as did students in their senior academic years. Vaccine uptake barriers included concerns about its side effects and a lack of information. Conclusions: Our findings can be used to formulate effective future awareness programs in the northern region of Saudi Arabia. A larger number of educational programs are required to enlighten Saudi women about cervical cancer and its prophylactic vaccine, including the benefits of screening programs and prevention strategies.

show abstract

“…37,38 As such, it is necessary to promote regular attendance of women, including female university students, to screening through increasing their awareness levels regarding concurrent HPV coinfection and enhance the implementation of organized screening programs in uncovered areas. [39][40][41] Such aspects should be stressed since only 15.8% of patients in our analysis were diagnosed at an early stage (stage I) of the disease, indicating the importance of early detection. This study has some limitations, which may impede generalizability of the findings.…”

Section: Predictormentioning

confidence: 99%

Indicators of survival and prognostic factors in women treated for cervical cancer at a tertiary care center in Saudi Arabia

Anfinan

Sait

2020

Ann Saudi Med

View full text Add to dashboard Cite

BACKGROUND: Investigating survival in cervical cancer at the local level is crucial to determine the effectiveness of overall management, as it reflects the level of care provided and awareness among the population about screening and early diagnosis. OBJECTIVES: Analyze overall survival (OS) and disease-free survival (DFS) among patients treated for cervical cancer and to investigate clinical, management-and outcome-related independent factors associated with survival. DESIGN: A retrospective medical record review. SETTING: Gynecology oncology unit in a tertiary care center. PATIENTS AND METHODS: All women with cervical cancer who were treated and followed up between January 1999 and December 2017. Baseline demographic and clinical data, tumor characteristics, treatment options and outcomes including recurrence were collected and analyzed as factors and predictors of survival. MAIN OUTCOME MEASURES: OS and DFS among patients treated for cervical cancer. SAMPLE SIZE: 190 patients. RESULTS: The 190 patients had a mean (SD) age of 54.2 (13.1) years (median 52.0, interquartile range, 46-62), and median (IQR) follow-up time was 37.0 (12.0-69.0) months. Tumor characteristics showed FIGO stage (I [19.0%], II [48.9%], III [18.4%], IV [13.6%]), grade (I [15.8%], II [46.8%], III [35.8%]) and the most frequent histological type was squamous cell carcinoma (77.4%). Patients received initial radiotherapy with concurrent chemotherapy (53.2%), initial radical hysterectomy (24.7%), systemic chemotherapy (6.3%) and palliative care (4.7%). Mean OS and DFS were 97.1 (82.2, 111.9) and 85.2 (70.4, 100.0) months, respectively. Recurrence and mortality rates were 25.8% and 46.8%, occurring after a median (IQR) time=13.0 (6.0-28.0) and 20.0 (9.0-45.0) months, respectively. Survival was independently associated with grade II (hazard ratio [HR]=3.6, 95%CI: 1.3-9.7, P=.012), grade III (HR=4.5, 95%CI:1.6-12.6, P=.004), number of regional organs involved (1-3 organs: HR=7.8, 95%CI: 1.2, 49.1, P=.030), and recurrence (HR=2.23, P=.001). CONCLUSION: Survival was about 8 years in our institution, which is predicted by the tumor grade, regional organs involved and recurrence. Remarkably, this study found a high percentage of patients diagnosed at an advanced stage, which probably impacts survival and stresses the need for improving early detection. LIMITATIONS: Retrospective design, resulting in recall bias and missing data. CONFLICT OF INTEREST: None.

show abstract

Knowledge, attitudes, and practices among Saudi women regarding cervical cancer, human papillomavirus (HPV) and corresponding vaccine

Cited by 45 publications

References 35 publications

Barriers, Attitudes and Clinical Approach of Lebanese Physicians Towards HPV Vaccination; A Cross- Sectional Study

Barriers, Attitudes and Clinical Approach of Lebanese Physicians Towards HPV Vaccination; A Cross- Sectional Study

Human papillomavirus and its vaccination: Knowledge and attitudes among female university students in Saudi Arabia

Indicators of survival and prognostic factors in women treated for cervical cancer at a tertiary care center in Saudi Arabia

Contact Info

Product

Resources

About